|
已选(0)清除
条数/页： 排序方式： |
| Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
  收藏 | 浏览/下载：31/0 | 提交时间：2020/10/26
PAINFUL DIABETIC-NEUROPATHY DOUBLE-BLIND PLACEBO PREVENTION MANAGEMENT TRIAL GABAPENTIN PREGABALIN ONCOLOGY TAXANES Duloxetine FACT-Tax Scales paclitaxel peripheral neuropathy |
| Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice 期刊论文
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2017, 卷号: 18
-
收藏 | 浏览/下载：27/0 | 提交时间：2020/10/26
RANDOMIZED PHASE-III NEOADJUVANT CHEMOTHERAPY ENCAPSULATED DOXORUBICIN 1ST-LINE CHEMOTHERAPY PROGNOSTIC MARKER PLUS DOCETAXEL COMBINATION CYCLOPHOSPHAMIDE TRASTUZUMAB PACLITAXEL Liposomal doxorubicin Breast cancer Adjuvant chemotherapy Therapeutic effect Toxic and side effects |
| Cervical granulocytic sarcoma 期刊论文
CHINESE MEDICAL JOURNAL, 2013, 卷号: 126
-
收藏 | 浏览/下载：35/0 | 提交时间：2020/10/26 |
| SPARC expression and prognostic value in non-small cell lung cancer 期刊论文
CHINESE JOURNAL OF CANCER, 2012, 卷号: 31
-
收藏 | 浏览/下载：29/0 | 提交时间：2020/10/26
ALBUMIN-BOUND PACLITAXEL MATRICELLULAR PROTEIN GROWTH-INHIBITION POOR-PROGNOSIS TUMOR PROGRESSION APOPTOSIS MARKERS HEAD RICH Non-small cell lung cancer prognosis SPARC |
| Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study 期刊论文
CHINESE MEDICAL JOURNAL, 2012, 卷号: 125
-
收藏 | 浏览/下载：38/0 | 提交时间：2020/10/26
PHASE-III GROWTH METAANALYSIS PLACEBO RISK bevacizumab metastatic breast cancer angiogenesis first-line Chinese docetaxel |
| Heterogeneity of chemosensitivity in esophageal cancer using ATP-tumor chemosensitivity assay 期刊论文
ACTA PHARMACOLOGICA SINICA, 2012, 卷号: 33
-
收藏 | 浏览/下载：23/0 | 提交时间：2020/10/26
IN-VITRO CHEMOSENSITIVITY OVARIAN-CANCER QUANTITATIVE-ANALYSIS DRUG RESPONSE CHEMOTHERAPY SENSITIVITY CISPLATIN THERAPY GEMCITABINE PREDICTION esophageal cancer chemotherapy heterogeneity nedaplatin cisplatin paclitaxel ATP-tumor chemosensitivity assay |
| Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer 期刊论文
CHINESE MEDICAL JOURNAL, 2010, 卷号: 123
-
收藏 | 浏览/下载：26/0 | 提交时间：2020/10/26
PHASE-III TRIAL PLUS DOCETAXEL MULTICENTER THERAPY PHOSPHORYLASE TOLERABILITY PACLITAXEL XELODA(R) SURVIVAL capecitabine weekly docetaxel metastatic breast cancer anthracycline elderly tolerability |
